| [ X ] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|-----------------|-----------------------------------------------------------------------------------------|

| CALIFORNIA                              |  333-29295  | 95-4298051                   |
|----------------------------------------------|-----------------------|------------------------------|
| State of  incorporation or organization | Commission File No.   | I.R.S. Identification Number |

|                                                                              |
|-----------------------------------------------------------------------------------|
| Former name, former address, and former fiscal year, if changed since last report |

| Large accelerated filer  [   ]                                                        | Accelerated filer  [   ] |
|-------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------|
| Non-accelerated filer   [   ] (Do not check if a smaller reporting company)      | Smaller reporting company  [ X ]   |

----

| Part I - FINANCIAL INFORMATION |                                                                                                                                                                                    |        |   |
|--------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|
| Item 1.                        | Financial Statements                                                                                                                                                                    |   |        |   |
|                           | Balance Sheets as of September 30, 2015 (unaudited) and December 31, 2014 (unaudited)                                                                               |   |   | 2 |   |
|                           | Statements of Operations (unaudited) for the Three and nine months ended September 30, 2015 and 2014, and for the Development Period from October 11, 2006 to September 30, 2015.  |   |   | 4 |   |
|                           | Statements of Cash Flows (unaudited) for the nine months ended September 30, 2015 and 2014,  and for the Development Period from October 11, 2006 to September 30, 2015       |   |   | 5 |   |
|                           | Notes to Financial Statements (unaudited)                                                                                                                                               |   |   | 6 |   |
| Item 2.                        | Management's Discussion and Analysis or Plan of Operation                                                                                                                               |   |   | 11 |   |
| Item 3.                        | Quantitative and Qualitative Disclosures About Market Risk                                                                                                                              |   |   | 14 |   |
| Item 4.                        | Controls and Procedures                                                                                                                                                                 |   |   | 14 |   |
|                           |                                                                                                                                                                                    |   |   |   |   |
| Part II - OTHER INFORMATION    |                                                                                                                                                                                    |   |   |   |
| Item 1.                        | Legal Proceedings                                                                                                                                                                       |   |   | 15 |   |
| Item 1A.                       | Risk Factors                                                                                                                                                                            |   |   | 15 |   |
| Item 2.                        | Unregistered Sales of Equity Securities and Use of Proceeds                                                                                                                             |   |   | 15 |   |
| Item 3.                        | Defaults Upon Senior Securities                                                                                                                                                         |   |   | 15 |   |
| Item 4.                        | Mine Safety Disclosures                                                                                                                                                                 |   |   | 15 |   |
| Item 5.                        | Other Information                                                                                                                                                                       |   |   | 15 |   |
| Item 6.                        | Exhibits                                                                                                                                                                                |   |   | 15 |   |
| SIGNATURES                     |                                                                                                                                                                                    |   | 16     |   |

----

|                                                    |   | September 30, 2015 |       |   | December 31, 2014 |   |
|--------------------------------------------------------------|--------|--------------------|------------|--------|-------------------|--------|
|                                                    |   | (Unaudited)        |       |   | (Unaudited)       |   |
| ASSETS                                                       |   |                    |       |   |                   |   |
|                                                         |   |                    |       |   |                   |   |
| Current assets:                                              |   |                    |       |   |                   |   |
|  Cash                                                   |   |               | -          |   |              |   | 0 |   |
| Total current assets                                         |   | $                  | -          |   |              | $      | - |   |
|                                                         |   |               |       |   |              |   |   |   |
|                                                         |   |               |       |   |              |   |   |   |
|                                                         |   |               |       |   |              |   |   |   |
|                                                         |   |               |       |   |              |   |   |   |
| LIABILITIES AND STOCKHOLDERS' (DEFICIT)                      |   |               |       |   |              |   |   |   |
|                                                         |   |               |       |   |              |   |   |   |
| Current liabilities:                                         |   |               |       |   |              |   |   |   |
| Accounts payable                                             |   | $                  | 3,270      |   |              | $      | 2,054 |   |
| Accrued expenses                                             |   |               | 3,175      |   |              |   | 2,575 |   |
| Advances payable - officer                                   |   |               | 6,934      |   |              |   | 6,934 |   |
| Notes payable - stockholders                                 |   |               | 198,266    |   |              |   | 198,266 |   |
| Accrued interest - stockholders                              |   |               | 102,338    |   |              |   | 90,475 |   |
| Total current liabilities                                    |   |               | 313,983    |   |              |   | 300,304 |   |
|                                                         |   |               |       |   |              |   |   |   |
| Commitments and contingencies (Notes 1, 2, 3, and 5)         |   |               |       |   |              |   |   |   |
|                                                         |   |               |       |   |              |   |   |   |
| Stockholders' (deficit):                                     |   |               |       |   |              |   |   |   |
| Preferred stock - no par value, authorized 1,000,000 shares: |   |               |       |   |              |   |   |   |
| No shares issued or outstanding                              |   |               | -          |   |              |   | - |   |
| Common stock - no par value, 100,000,000 shares authorized:  |   |               |       |   |              |   |   |   |
| 14,425,903 shares issued and outstanding                     |   |               | 6,903,766  |   |              |   | 6,903,766 |   |
| Additional paid-in capital                                   |   |               | 235,873    |   |              |   | 234,353 |   |
| Accumulated deficit through October 11, 2006                 |   |               | (7,302,235 | )      |              |   | (7,302,235 | ) |
| (Accumulated deficit) during development stage               |   |               | (151,387   | )      |              |   | (136,188 | ) |
| Total stockholders' (deficit)                                |   |               | (313,983   | )      |              |   | (300,304 | ) |
|                                                         |   |               |       |   |              |   |   |   |
| Total liabilities and stockholders' (deficit)                |   | $                  | (0.04      | )      |              | $      | 0.00 |   |

----

|                                 |   | 2015   |       |   | 2014   |   |
|--------------------------------------|--------|--------|------------|--------|--------|--------|
|                                 |   |        |       |   |        |   |
|                                 |   |        |       |   |        |   |
| Revenues                             |   | $      | -          |   |   | $      | - |   |
|                                 |   |   |       |   |   |   |   |   |
| Expenses:                            |   |   |       |   |   |   |   |   |
| General and administrative:          |   |   |       |   |   |   |   |   |
| Financing costs                      |   |   | -          |   |   |   | - |   |
| Consulting fees                      |   |   | -          |   |   |   | - |   |
| Accounting and legal                 |   |   | 249        |   |   |   | 525 |   |
| Investor relations                   |   |   | 693        |   |   |   | 570 |   |
| Total expenses                       |   |   | 942        |   |   |   | 1,095 |   |
|                                 |   |   |       |   |   |   |   |   |
| Operating (loss)                     |   |   | (942       | )      |   |   | (1,095 | ) |
|                                 |   |   |       |   |   |   |   |   |
| Other income (expense):              |   |   |       |   |   |   |   |   |
| Gain from litigation settlement      |   |   | -          |   |   |   | - |   |
| Interest (expense)                   |   |   | (3,998     | )      |   |   | (3,998 | ) |
|                                 |   |   | (3,998     | )      |   |   | (3,998 | ) |
|                                 |   |   |       |   |   |   |   |   |
| Income (loss) before income taxes    |   |   | (4,940     | )      |   |   | (5,093 | ) |
|                                 |   |   |       |   |   |   |   |   |
| Provision for income taxes           |   |   | 200        |   |   |   | 200 |   |
|                                 |   |   |       |   |   |   |   |   |
| Net income (loss)                    |   | $      | (5,140     | )      |   | $      | (5,293 | ) |
|                                 |   |   |       |   |   |   |   |   |
|                                 |   |   |       |   |   |   |   |   |
|                                 |   |   |       |   |   |   |   |   |
|                                 |   |   |       |   |   |   |   |   |
| Net (loss) per common share:         |   |   |       |   |   |   |   |   |
| Basic and Diluted                    |   | $      | Nil        |   |   | $      | Nil |   |
|                                 |   |   |       |   |   |   |   |   |
| Weighted average shares outstanding: |   |   |       |   |   |   |   |   |
| Basic and Diluted                    |   |   | 14,425,903 |   |   |   | 14,425,903 |   |

----

|                                 |   |        |       |   |        |   |       |                    |   |
|--------------------------------------|--------|--------|------------|--------|--------|--------|------------|--------------------|--------|
|                                 |   |        |       |   |        |   |       | Development Period |   |
|                                 |   |        |       |   |        |   |       | October 11, 2006   |   |
|                                 |   | 2015   |       |   | 2014   |   |       | to Sept 30, 2015   |   |
|                                 |   |        |       |   |        |   |       |                    |   |
|                                 |   |        |       |   |        |   |       |                    |   |
| Revenues                             |   | $      | -          |   |   | $      | -          |               |   | $ | - |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Expenses:                            |   |   |       |   |   |   |       |               |   |   |   |   |
| General and administrative:          |   |   |       |   |   |   |       |               |   |   | - |   |
| Financing costs                      |   |   | -          |   |   |   | -          |               |   |   | 2,917 |   |
| Consulting fees                      |   |   | -          |   |   |   | -          |               |   |   | 8,029 |   |
| Accounting and legal                 |   |   | 1,149      |   |   |   | 1,538      |               |   |   | 127,454 |   |
| Investor relations                   |   |   | 1,587      |   |   |   | 2,062      |               |   |   | 40,506 |   |
| Total expenses                       |   |   | 2,736      |   |   |   | 3,600      |               |   |   | 178,907 |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Operating (loss)                     |   |   | (2,736     | )      |   |   | (3,600     | )                  |   |   | (178,907 | ) |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Other income (expense):              |   |   |       |   |   |   |       |               |   |   |   |   |
| Gain from litigation settlement      |   |   | -          |   |   |   | -          |               |   |   | 137,310 |   |
| Interest (expense)                   |   |   | (11,863    | )      |   |   | (12,160    | )                  |   |   | (102,338 | ) |
|                                 |   |   | (11,863    | )      |   |   | (12,160    | )                  |   |   | 34,972 |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Income (loss) before income taxes    |   |   | (14,599    | )      |   |   | (15,760    | )                  |   |   | (143,934 | ) |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Provision for income taxes           |   |   | 600        |   |   |   | 600        |               |   |   | 7,590 |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Net income (loss)                    |   | $      | (15,199    | )      |   | $      | (16,360    | )                  |   | $ | (151,524 | ) |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Net (loss) per common share:         |   |   |       |   |   |   |       |               |   |   |   |   |
| Basic and Diluted                    |   | $      | Nil        |   |   | $      | Nil        |               |   |   |   |   |
|                                 |   |   |       |   |   |   |       |               |   |   |   |   |
| Weighted average shares outstanding: |   |   |       |   |   |   |       |               |   |   |   |   |
| Basic and Diluted                    |   |   | 14,425,903 |   |   |   | 14,425,903 |               |   |   |   |   |

----

|                                                   |   |        |    |   |        |   |    | Development Period    |   |
|--------------------------------------------------------|--------|--------|---------|--------|--------|--------|---------|-----------------------|--------|
|                                                   |   |        |    |   |        |   |    | October 11, 2006      |   |
|                                                   |   | 2015   |    |   | 2014   |   |    | to September 30, 2015 |   |
|                                                   |   |        |    |   |        |   |    |                       |   |
|  Cash flows from operating activities:            |   |        |    |   |        |   |    |                       |   |
|  Net income (loss)                                |   | $      | (15,199 | )      |   | $      | (17,205 | )                     |   | $ | (122,198 | ) |
| Adjustments to reconcile net income (loss) to net cash |   |   |    |   |   |   |    |                  |   |
|  used by operating activities:                    |   |   |    |   |   |   |    |                  |   |   |   |   |
|  Gain from litigation settlement                  |   |   |    |   |   |   |    |                  |   |   | (137,310 | ) |
| Shares issued for loan fees and consulting fees        |   |   |    |   |   |   |    | 10,946                |   |
| Changes in operating assets and liabilities:           |   |   |    |   |   |   |    |                  |   |
|  Accounts payable                                 |   |   | 1,216   |   |   |   | (5,312  | )                     |   |   | (5,730 | ) |
|  Accrued expenses                                 |   |   | 600     |   |   |   | 75      |                  |   |   | 2,700 |   |
|  Judgement payable                                |   |   |    |   |   |   |    |                  |   |   | (27,750 | ) |
|  Accrued interest                                 |   |   | 11,863  |   |   |   | 11,172  |                  |   |   | 83,637 |   |
|  Total adjustments                                |   |   | 13,679  |   |   |   | 5,935   |                  |   |   | (73,507 | ) |
|                                                   |   |   |    |   |   |   |    |                  |   |   |   |   |
| Net cash (used in) operating activities                |   |   | (1,520  | )      |   |   | (11,270 | )                     |   |   | (195,705 | ) |
|                                                   |   |   |    |   |   |   |    |                  |   |   |   |   |
|  Cash flows from investing activities:            |   |   |    |   |   |   |    |                  |   |   |   |   |
| Net cash (used in) investing activities                |   |   | -       |   |   |   | -       |                  |   |   | - |   |
|                                                   |   |   |    |   |   |   |    |                  |   |   |   |   |
| Cash flows from financing activities:                  |   |   |    |   |   |   |    |                  |   |   |   |   |
|   Proceeds from notes payable - stockholders |   |   |    | 11,270 |   |   |    | 182,898               |   |
| Cash Proceeds from add'l Paid in Capital               |   |   | 1,520   |   |   |   |    |                  |   |   | 5,873 |   |
| Advances from officer                                  |   |   |    |   |   |   |    |                  |   |   | 6,934 |   |
| Net cash provided by financing activities              |   |   | 1,520   |   |   |   | 11,270  |                  |   |   | 195,705 |   |
|                                                   |   |   |    |   |   |   |    |                  |   |   |   |   |
| Net increase in cash and equivalents                   |   |   | -       |   |   |   | -       |                  |   |   | - |   |
|                                                   |   |   |    |   |   |   |    |                  |   |   |   |   |
| Cash and equivalents at beginning of year              |   |   | -       |   |   |   | -       |                  |   |   | - |   |
|                                                   |   |   |    |   |   |   |    |                  |   |   |   |   |
| Cash and equivalents at end of year                    |   | $      | -       |   |   | $      | -       |                  |   | $ | - |   |
|                                                   |   |   |    |   |   |   |    |                  |   |   |   |   |
|                                                   |   |   |    |   |   |   |    |                  |   |   |   |   |
| Supplemental Cash Flow Information                     |   |   |    |   |   |   |    |                  |   |   |   |   |
| Interest paid                                          |   | $      | -       |   |   | $      | -       |                  |   | $ | - |   |
| Income taxes paid                                      |   | $      | -       |   |   | $      | -       |                  |   | $ | 7,670 |   |

----

----

----

----

----

| Period Ending           |   | Estimated NOL Carry-forward |   | NOL Expires |   | Estimated Tax Benefit from NOL |   | Valuation Allowance |   | Change in Valuation Allowance | Net Tax Benefit |
|-------------------------|--------|-----------------------------|--------|-------------|--------|--------------------------------|--------|---------------------|--------|-------------------------------|-----------------|
| December 31, 2014       |   | $ 500,000                   |   | Various     |   | 113,250                        |   | (113,250)           |   | $(-0-)                        | $—        |
|  September30, 2015 |   | 11,863                      |   | 2035        |   | $0                             |   | $(0)                |   | 0                             | $—        |
| Federal tax expense (benefit) at statutory rate |   |   | (15.00 | %) |
|-------------------------------------------------|--------|--------|--------|----|
| State tax expense (benefit), net of federal tax |   |   | (7.65  | %) |
| Deferred income tax valuation allowance         |   |   | 22.65  | %  |
| Reported tax rate                               |   |   | 0      | %  |

----

----

----

| · | The worldwide economic situation; |
|--------|-----------------------------------|

| · | Any change in interest rates or inflation; |
|--------|--------------------------------------------|

| · | The willingness and ability of third parties to honor their contractual commitments; |
|--------|--------------------------------------------------------------------------------------|

| · | Our ability to raise additional capital, as it may be affected by current conditions in the stock market and competition for risk capital; |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------|

| · | Environmental and other regulations, as the same presently exist and may hereafter be amended. |
|--------|------------------------------------------------------------------------------------------------|

----

|  | 31.1 | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 for Borivoje Vukadinovic. |
|--|------|---------------------------------------------------------------------------------------------------|

|  | 32.1 | Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Borivoje Vukadinovic. |
|--|------|---------------------------------------------------------------------------------------------------|

|  | 101 | Interactive Data Files * |
|--|-----|--------------------------|

----

|                          | RETROSPETTIVA, INC |                                                                                 |
|-------------------------------|--------------------|--------------------------------------------------------------------------------------|
|                          |               |                                                                                 |   |
| Date:  December 11, 2015 | By:                | /s/ Borivoje Vukadinovic                                                        |   |
|                          |               | Borivoje Vukadinovic, Director, Chief Executive Officer, and Chief Financial Officer |   |
|                          |               |                                                                                      |   |
|                          |               |                                                                                 |   |